Interrogate COVID-19 and get more answers

Use our portfolio of research and diagnostic tools to gain deeper insights from your COVID-19 samples.

Tools for coronavirus research and immune status assessment

If COVID-19 were a person, they would stand accused of one of the most heinous crimes against humanity. They would be apprehended and interrogated using every technique known to mankind.


Our new COVID-19 toolbox contains several tests that generate additional data to understand the novel coronavirus SARS-CoV-2. This includes our new test for antibody detection, offering novel insights together with the previously available kits for general research into infectious disease and cellular responses.

Our COVID-19 portfolio – solutions for coronavirus etiology

This comprehensive portfolio provides high quality tools to get more from your samples. Our assays and kits have been designed to test challenging viral samples, and optimized to deliver consistent qualitative and quantitative data. This provides a combination of methods such as highly sensitive viral detection using qPCR; reliable serological ELISA testing of HMGB1 / Neopterin / SARS-CoV-2 S1/RBD IgG antibody to assess immunity and etiology of immune response to coronavirus; as well as full viral genome characterization with RNA-Seq.


This complete toolkit, from a single provider, can provide more information through additional testing of your SARS-CoV-2 samples, helping in the fight against the pandemic.

Revelo™ RNA-Seq

Uncover SARS-CoV-2 from nasal swabs of any quality with our easily automated RNA-Seq solution.

If your library preparation kit isn’t specifically designed for viral pathogen sequencing, then you’re probably missing data. Revelo RNA-Seq is an integrated NGS library preparation and QC solution that provides exceptional sensitivity to identify and characterize pathogens from low quality samples, such as nasal swabs.

Read more

Crescendo cDNA™ Synthesis for qPCR

Exceptional sensitivity for qPCR studies from low input and degraded samples.

Was that sample really negative? Or did your current protocol just fail to detect it? RNA isolated from COVID-19 nasal swab samples can vary significantly in quantity, quality and viral titers, making it difficult to interrogate.

Read more

HMGB1 Express ELISA

Additional valuable COVID-19 aetiology insights based on the immune system’s inflammatory response to a pathogen.

HMGB1 is involved in intracellular signaling, immune regulation, inflammation and cell death. With this functional repertoire, HMGB1 is a promising biomarker that may deepen, and even change, our understanding of COVID-19 disease development.

Read more

Neopterin ELISA

A sensitive ELISA that enables the early detection of any infection, including SARS-CoV-2.

Neopterin can serve as a biomarker for infection of the body by invading pathogens. Neopterin concentrations rise before symptoms are present, and decrease as the immune system starts to produce antibodies. This makes it an ideal marker for detecting potential pathogen invasion, which could include SARS-CoV-2.

Read more

SARS-CoV-2 S1/RBD IgG Ab ELISA

A quantitative ELISA detecting IgG antibodies directed against SARS-CoV-2-S1 Receptor Binding Domain (RBD).

Serological testing of IgG antibodies directed against SARS-CoV-2 plays an essential role in determining the prevalence of the virus. Efficient immune status monitoring can be used for prescreening of individuals before vaccination, as well as for investigating post-vaccination responses.

Read more

Regulatory status of the products:

  • Research Use Only: Revelo™ RNA-Seq and Crescendo cDNA™ Synthesis for qPCR.
  • Europe: CE IVD: HMGB1 Express ELISA, Neopterin ELISA and SARS-CoV-2 S1/RBD IgG Ab ELISA.

Not all products are available in all countries. Please contact your local Tecan representative.